Pfizer announced an experimental vaccine that, when administered during pregnancy, would protect infants from severe illness for up to six months of life.
"These data reinforce Pfizer’s resolve to bring our expertise in the research and development of innovative vaccines to address critical public health needs using new approaches and technologies.
We look forward to working with the FDA and other regulatory agencies to bring this vaccine candidate to expectant mothers to help protect their infants against severe RSV during their most vulnerable first six months of life, which has the highest burden of RSV illness in infants.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer stock climbs on Q3 top and bottom line beat, raised outlookPfizer Inc.'s undefined stock rose 3.4% before market open on Tuesday, lifted by the pharmaceutical giant's third-quarter earnings. The company earned $1.51...
Read more »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Read more »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Read more »
RSV Vaccine Protected Infants From Severe Cases, Pfizer Study FindsAn RSV vaccine given to pregnant women significantly reduced the risk of severe cases in their infants. The study comes as doctors report unusually high numbers of the respiratory illness.
Read more »
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data showsPfizer said it will submit an application to the Food and Drug Administration for the RSV vaccine's approval by the end of 2022.
Read more »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Read more »